GLPBio

Glucagon Receptor

Glucagon receptor is a member of the class B G-protein coupled family of receptors and is activated by glucagon, resulting in activation of adenylate cyclase and increased levels of intracellular cAMP.

Products Related to Glucagon Receptor(54)

  • GC10075 structure
    GC10075Methylprednisolone Sodium Succinate
    CAS: 2375-03-3
    Purity: >98.00%

    glucocorticoid

  • GC10311 structure
    GC10311Liraglutide
    CAS: 204656-20-2
    Purity: >98.00%

    Liraglutide is a novel human glucagon-like peptide-1 (GLP-1) receptor agonist.

  • GC11646 structure
    GC11646des-His1-[Glu9]-Glucagon (1-29) amide
    CAS: 110084-95-2
    Purity: >98%

    des-His1-[Glu9]-Glucagon (1-29) amide is a potent and peptide antagonist of the glucagon receptor, with a pA2 of 7.2.

  • GC12569 structure
    GC12569glucagon receptor antagonists 2
    CAS: 202917-18-8
    Purity: >98%
  • GC13075 structure
    GC13075GLP-2 (rat)
    CAS: 195262-56-7
    Purity: >98%

    intestinal epithelium-specific growth factor

  • GC13391 structure
    GC13391Exendin-4
    CAS: 141758-74-9
    Purity: >99.00%

    Exendin-4 is a 39-amino-acid polypeptide (48-86) and a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist with an IC 50 of 3.22 nM.

  • GC13512 structure
    GC13512glucagon receptor antagonists 3
    CAS: 202917-17-7
    Purity: >98.50%
  • GC13743 structure
    GC13743GLP-1 (9-36) amide
    CAS: 161748-29-4
    Purity: >99.00%

    antagonist at the human GLP-1 receptor

  • GC14793 structure
    GC14793MK 0893
    CAS: 870823-12-4
    Purity: >99.00%

    MK 0893 is a potent and selective glucagon receptor (GCGR) antagonist with an IC 50 value of 6.6 nM.

  • GC15486 structure
    GC15486glucagon receptor antagonists 1
    CAS: 503559-84-0
    Purity: >98%
  • GC16232 structure
    GC16232BETP
    CAS: 1371569-69-5
    Purity: >99.00%

    glucagon-like peptide 1 (GLP-1) receptor modulator

  • GC16482 structure
    GC16482Exendin-3 (9-39) amide
    CAS: 133514-43-9
    Purity: >98.00%

    Exendin3(9-39) amide is a specific exendin receptor antagonist. Exendin-3 increased cellular cAMP levels and amylase release from dispersed acini from guinea pig pancreas.

  • GC16646 structure
    GC16646GLP-2(1-33) (human)
    CAS: 223460-79-5
    Purity: >99.00%

    GLP-2(1-33) (human) is an endocrine hormone that is released from the intestinal L-cell in response to nutrient ingestion.

  • GC16969 structure
    GC16969Oxyntomodulin
    CAS: 62340-29-8
    Purity: >98.00%

    Oxyntomodulin is a 37-amino-acid peptide hormone that simultaneously activates both the glucagon-like peptide-1 receptor and the glucagon receptor, thereby regulating appetite, energy expenditure, and blood glucose levels.

  • GC17298 structure
    GC17298L-168,049
    CAS: 191034-25-0
    Purity: >98%

    human glucagon receptor (hGR) antagonist

  • GC19170 structure
    GC19170Glucagon receptor antagonists-4
    CAS: 1393124-08-7
    Purity: >99.50%

    Glucagon receptor antagonists-4 is a highly potent, non-peptide and orally active glucagon receptor antagonist.

  • GC25046 structure
    GC25046Albiglutide Fragment
    CAS: 782500-75-8
    Purity: >98.00%

    Albiglutide Fragment is the active fragment (7-36) of Albiglutide, a glucagon-like peptide-1 (GLP-1) mimetic belonging to the class of long-acting GLP-1 receptor agonists.

  • GC26027 structure
    GC26027V-0219
    CAS: 878453-71-5
    Purity: >98%

    V-0219 is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), can be used for obesity-associated diabetes research.

  • GC30058 structure
    GC30058GLP-1(7-37)
    CAS: 106612-94-6
    Purity: >99.50%

    GLP-1(7-37) is a truncated glucagon-like peptide with an EC 50 value of 0.9 ± 0.1nM for GLP-1 receptors.

  • GC30254 structure
    GC30254HAEGTFT
    CAS: 926018-95-3
    Purity: >99.00%

    HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.

  • GC31322 structure
    GC31322Adomeglivant (LY2409021)
    CAS: 1488363-78-5
    Purity: >98.00%

    Adomeglivant (LY2409021) is a potent, selective, orally administered, competitive, small-molecule antagonist of the glucagon receptor, with a K i value of 6.66nM.

  • GC31334 structure
    GC31334Lixisenatide
    CAS: 320367-13-3
    Purity: >98.00%

    Lixisenatide is a glucagon-like peptide-1 receptor (GLP-1 receptor) agonist that can be used for the treatment of type 2 diabetes.

  • GC31343 structure
    GC31343LGD-6972
    CAS: 1207989-09-0
    Purity: >98.00%

    LGD-6972 is a selective and orally active glucagon receptor antagonist.

  • GC31360 structure
    GC31360Taspoglutide (ITM077)
    CAS: 275371-94-3
    Purity: >98.00%

    Taspoglutide (ITM077) is a novel analog of human glucagon-like peptide-1 [hGLP-1(7-36)NH 2 ] in clinical development for the treatment of type 2 diabetes. Taspoglutide inhibits VEGFR2 in CHO cells with an IC 50 value of 4.6±0.6nM.